Advertisement
Document › Details
GlaxoSmithKline plc. (7/20/17). "Press Release: ViiV Healthcare Shares Data from Its Innovative Portfolio with HIV Community at IAS 2017". London.
Region | Paris | |
Country | France | |
Organisation | ViiV Healthcare | |
Group | GSK (Group) | |
Organisation 2 | International AIDS Society (IAS) | |
Product | dolutegravir (DTG) | |
Product 2 | cabotegravir | |
Person | Pottage, John C., Jr. (GSK 201311 CMO of ViiV Healthcare) | |
Original document
accessed by [iito] on 2017-07-21
Record changed: 2023-06-05 |
Advertisement
More documents for GSK (Group)
- [1] Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion"....
- [2] GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio"....
- [3] CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA....
- [4] GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London....
- [5] Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London....
- [6] GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London....
- [7] LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren....
- [8] GSK plc. (6/28/23). "Press Release: GSK Completes Acquisition of Bellus Health [For media and investors only]". London....
- [9] GSK plc. (4/18/23). "Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Bellus Health [For media and investors only]". London....
- [10] CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top